Cargando…
Peroxisome Proliferator-Activated Receptors in HBV-Related Infection
Thirty years after its discovery, the hepatitis B virus (HBV) still remains a major global public health problem. Worldwide, two billion subjects have been infected, 350 million have a chronic infection and more than 600 000 die annually of HBV-related liver disease or hepatocellular carcinoma; new...
Autores principales: | Dubuquoy, Laurent, Louvet, Alexandre, Hollebecque, Antoine, Mathurin, Philippe, Dharancy, Sébastien |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2667936/ https://www.ncbi.nlm.nih.gov/pubmed/19365584 http://dx.doi.org/10.1155/2009/145124 |
Ejemplares similares
-
Peroxisome Proliferator-Activated Receptors in HCV-Related Infection
por: Dharancy, Sébastien, et al.
Publicado: (2009) -
Peroxisome proliferator‐activated receptor gamma (PPARγ) regulates lactase expression and activity in the gut
por: Fumery, Mathurin, et al.
Publicado: (2017) -
Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator–activated receptor-γ
por: Rousseaux, Christel, et al.
Publicado: (2005) -
The Expression of the Short Isoform of Thymic Stromal Lymphopoietin in the Colon Is Regulated by the Nuclear Receptor Peroxisome Proliferator Activated Receptor-Gamma and Is Impaired during Ulcerative Colitis
por: Martin Mena, Anthony, et al.
Publicado: (2017) -
Benefits of tailored hepatocellular carcinoma screening in patients with cirrhosis on cancer‐specific and overall mortality: A modeling approach
por: Ningarhari, Massih, et al.
Publicado: (2022)